Private Equity

Updated:

Finnova Capital

Finnova Capital is a China-based venture capital firm investing in energy-saving, clean energy, healthcare, information technology, new materials, and other...

Finnova Capital logo

Finnova Capital

Finnova Capital is a China-based venture capital firm investing in energy-saving, clean energy, healthcare, information technology, new materials, and other areas. The firm has made 28 investments, including a Seed VC investment in Crygan on March 12, 2026. Finnova Capital has facilitated 3 portfolio exits, with Bao Pharma exiting on December 10, 2025.

General information

Firm type

Private Equity

Year founded

2015

Location

Region

Asia

Country

China

City

Beijing

Corporate office

Beijing, China

Frequently asked questions

What stages does Finnova Capital invest across?

Finnova deploys capital across the full lifecycle of private Chinese companies, from early-stage seed and start-up venture rounds through growth equity and expansion capital. The firm also executes pre-IPO placements and participates in PIPE transactions, which allows it to back companies from initial institutional funding through to public-market adjacency. This multi-stage approach is designed to capture value across the entire private growth curve.

Is Finnova Capital a domestic Chinese fund or does it have an offshore structure?

Finnova Capital operates as a Beijing-headquartered asset manager focused almost exclusively on domestically incorporated Chinese portfolio companies. There is no public record of significant offshore fund vehicles or a Cayman Islands master-feeder structure, which is typical for Chinese GPs raising foreign LP capital. Its mandate and deal flow appear entirely Renminbi-denominated and mainland-facing.

Does Finnova Capital participate in fund commitments from foreign limited partners?

There is no available evidence that Finnova has historically raised capital from foreign LPs. Its operational footprint, Renminbi deal activity, and lack of a disclosed offshore structure indicate it is funded by domestic Chinese institutional investors, high-net-worth individuals, or proprietary capital from its founding principals.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on private equity firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More Beijing Private Equity profiles